Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA Director-Nominee Guido Rasi Brings Track Record For Repairing Regulatory Agency Reputation

This article was originally published in The Pink Sheet Daily

Executive Summary

Rasi leads the Italian Medicines Agency, an agency also known for conditional reimbursement agreements.
Advertisement

Related Content

EMA’s Heralded Revamp May Be Hampered By Tight Budget And Staffing
European Generics Applications Fall, As EMA’s Interim Report Hopes To Herald Funding Renewal
Biosimilars Guidance On Interferon Beta From EMA Foreshadows Possible Joint EU/U.S. Approach
European Regulatory Round-Up: Patents, Pricing And Parabens
Mediator Is Tip Of EU Parliament's Probe Into EMA; Funding Held In Balance
Mediator Is Tip Of EU Parliament's Probe Into EMA; Funding Held In Balance
Italy Leads European Push Into Conditional Reimbursement
Ex-Chief Of Europe's Regulatory Agency To Be Kept On A Tight Rein

Topics

Advertisement
UsernamePublicRestriction

Register

PS072484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel